Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematologically important mutations: leukocyte adhesion deficiency.

D Roos1, S K Law

  • 1Department of Experimental Immunohematology, CLB, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. d_roos@clb.nl

Blood Cells, Molecules & Diseases
|February 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study.

Annals of surgical oncology·2024
Same author

What drives wild boar density and population growth in Mediterranean environments?

The Science of the total environment·2024
Same author

Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Same author

Are face masks useful for limiting the spread of COVID-19?

Hong Kong medical journal = Xianggang yi xue za zhi·2020
Same author

Is reinfection possible after recovery from COVID-19?

Hong Kong medical journal = Xianggang yi xue za zhi·2020
Same journal

Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis.

Blood cells, molecules & diseases·2026
Same journal

Propofol attenuates H<sub>2</sub>O<sub>2</sub>-induced senescence in human umbilical vein endothelial cells by activating the NRF2/HO-1 axis.

Blood cells, molecules & diseases·2026
Same journal

Is it time to implement a hemorheology passport in sickle cell disease?

Blood cells, molecules & diseases·2026
Same journal

From blood viscosity to a hemorheology passport: Making sickle-cell monitoring clinically actionable.

Blood cells, molecules & diseases·2026
Same journal

A real-world analysis of polycythemia vera at two comprehensive cancer centers in Cali, Colombia.

Blood cells, molecules & diseases·2026
Same journal

Sickle Cell Disease: Can genetic variability influence pregnancy outcomes?

Blood cells, molecules & diseases·2026
See all related articles

Leukocyte adhesion deficiency (LAD) is an immunodeficiency impairing bacterial defense and wound healing. This review details known genetic mutations in LAD-I and LAD-II, crucial for understanding disease mechanisms.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Leukocyte adhesion deficiency (LAD) is a group of primary immunodeficiencies characterized by impaired leukocyte (especially neutrophil) adhesion to blood vessel walls.
  • This adhesion defect leads to recurrent severe bacterial infections and compromised wound healing in affected individuals.
  • LAD encompasses distinct subtypes, including LAD-I and LAD-II, each with unique molecular underpinnings.

Purpose of the Study:

  • To comprehensively review and summarize all documented patient mutations and polymorphisms in the genes associated with Leukocyte Adhesion Deficiency.
  • To provide an updated genetic landscape of LAD-I and LAD-II for researchers and clinicians.
  • To consolidate information on genetic variations impacting leukocyte function and immune response.

Main Methods:

Related Experiment Videos

  • Literature review of published studies on Leukocyte Adhesion Deficiency.
  • Systematic compilation of identified mutations and polymorphisms in the INTG2 gene (LAD-I).
  • Systematic compilation of identified mutations and polymorphisms in the GDP-fucose transporter gene (LAD-II).

Main Results:

  • LAD-I is primarily caused by mutations in the ITGB2 gene, encoding the beta-2 integrin subunit, essential for leukocyte adhesion.
  • LAD-II results from mutations affecting the GDP-fucose transporter in the Golgi, disrupting selectin ligand fucosylation and subsequent leukocyte trafficking.
  • The article presents a comprehensive catalog of known patient mutations and polymorphisms for both LAD-I and LAD-II.

Conclusions:

  • Genetic defects in leukocyte adhesion, as seen in LAD-I and LAD-II, result in severe immunodeficiency with distinct molecular causes.
  • Understanding the spectrum of mutations and polymorphisms is critical for accurate diagnosis, genetic counseling, and potential therapeutic strategies.
  • This review serves as a valuable resource for the scientific and medical community studying leukocyte adhesion and primary immunodeficiencies.